Info

MediCor was founded in 1999 by chairman of the board Donald K. McGhan, the founder and former chairman and chief executive officer of Inamed Corporation, McGhan Medical and McGhan Limited. MediCor is driven to be a leading supplier of selected medical devices and technologies on a global basis. To achieve our objective, we intend to build upon and expand our business lines, primarily in the aesthetic, plastic and reconstructive surgery and dermatology markets. Our management team has world-class experience in these target markets, and in particular the breast implant market. From the outset we focused our strategy on acquiring manufacturing and the right to distribute products in the breast implant market. We intend this focus to position the Company to become the world leader in this market. We have executed on our strategy by: acquiring the world's third largest breast implant manufacturer, France-based Eurosilicone; acquiring the North America distribution rights to two other leading international breast implant manufacturers, Biosil Limited and Poly Implant Protheses S.A.; and acquiring the world's leading scar management product company, Biodermis. We intend to continue to accomplish our targeted growth through the expansion of existing product lines and offerings through the development of new products. MediCor will meet this expansion through the acquisition of companies and other assets, including intellectual property rights and distribution rights.